Assembly and maturation of synapses at the Drosophila neuromuscular junction (NMJ) depend on trans-synaptic neurexin/neuroligin signalling, which is promoted by the scaffolding protein Syd-1 binding to neurexin. Here we report that the scaffold protein spinophilin binds to the C-terminal portion of neurexin and is needed to limit neurexin/neuroligin signalling by acting antagonistic to Syd-1. Loss of presynaptic spinophilin results in the formation of excess, but atypically small active zones. Neuroligin-1/neurexin-1/Syd-1 levels are increased at spinophilin mutant NMJs, and removal of single copies of the neurexin-1, Syd-1 or neuroligin-1 genes suppresses the spinophilin-active zone phenotype. Evoked transmission is strongly reduced at spinophilin terminals, owing to a severely reduced release probability at individual active zones. We conclude that presynaptic spinophilin fine-tunes neurexin/neuroligin signalling to control active zone number and functionality, thereby optimizing them for action potential-induced exocytosis.
Assembly and maturation of synapses at the Drosophila neuromuscular junction (NMJ) depend on trans-synaptic neurexin/neuroligin signalling, which is promoted by the scaffolding protein Syd-1 binding to neurexin. Here we report that the scaffold protein spinophilin binds to the C-terminal portion of neurexin and is needed to limit neurexin/neuroligin signalling by acting antagonistic to Syd-1. Loss of presynaptic spinophilin results in the formation of excess, but atypically small active zones. Neuroligin-1/neurexin-1/Syd-1 levels are increased at spinophilin mutant NMJs, and removal of single copies of the neurexin-1, Syd-1 or neuroligin-1 genes suppresses the spinophilin-active zone phenotype. Evoked transmission is strongly reduced at spinophilin terminals, owing to a severely reduced release probability at individual active zones. We conclude that presynaptic spinophilin fine-tunes neurexin/neuroligin signalling to control active zone number and functionality, thereby optimizing them for action potential-induced exocytosis.
Chemical synapses release synaptic vesicles (SVs) at specialized presynaptic membranes,
so-called active zones (AZs), which are characterized by electron-dense structures,
reflecting the presence of extended molecular protein scaffolds. These AZ scaffolds
confer stability and facilitate SV release1. Importantly, at individual
AZs, scaffold size is found to scale with the propensity to engage in action
potential-evoked release234. An evolutionarily conserved set of large
multi-domain proteins operating as major building blocks for these scaffolds has been
identified over the last years: Syd-2/Liprin-α, RIM, RIM-binding-protein (RBP)
and ELKS family proteins (of which the the Drosophila homologue is called
Bruchpilot (BRP))1567. However, how presynaptic scaffold assembly
and maturation are controlled and coupled spatiotemporally to the postsynaptic assembly
of neurotransmitter receptors remains largely unknown, although trans-synaptic
signalling via Neurexin-1 (Nrx-1)–Neuroligin-1 (Nlg1) adhesion molecules is a
strong candidate for a conserved ‘master module' in this context,
based on Nrx-Nlg signalling promoting synaptogenesis in vitro, synapses of
rodents89, Caenorhabditis elegans10 and
Drosophila111213141516. With respect to scaffolding
proteins, Syd-1 was found to promote synapse assembly in C. elegans5, Drosophila17 and rodents18. In
Drosophila, the Syd-1-PDZ domain binds the Nrx-1 C terminus and couples pre-
with postsynaptic maturation at nascent synapses of glutamatergic neuromuscular
junctions (NMJs) in Drosophila larvae. Syd-1 cooperates with Nrx-1/Nlg1 to
stabilize newly formed AZ scaffolds, allowing them to overcome a
‘threshold' for synapse formation13. Additional
factors tuning scaffold assembly, however, remain to be identified. We show here that
the conserved scaffold protein spinophilin (Spn) is able to fine-tune Nrx-1 function by
binding the Nrx-1 C terminus with micromolar affinity via its PDZ domain. In the absence
of presynaptic Spn, ‘excessive seeding' of new AZs occurred over the
entire NMJ due to elevated Nrx-1/Nlg1 signalling. Apart from structural changes, we show
that Spn plays an important role in neurotransmission since it is essential to establish
proper SV release probability, resulting in a changed ratio of spontaneous versus evoked
release at Spn NMJ terminals.
Results
Presynaptic Spn restricts the AZ number
Glutamatergic NMJs of Drosophila larvae continuously expand to meet the
requirements of the growing muscle fibres by adding new release sites (or
synapses) to their structure1920. These synapses are
characterized by a single presynaptic AZ opposed by a single postsynaptic
density (PSD) composed of glutamate receptors (GluRs). AZ formation is initiated
by both Syd-1 and Liprin-α clusters and finalized by the incorporation
of BRP21. Here we used the Drosophila NMJ model system to
search for factors restricting the number of BRP scaffolds. To this end, a set
of proteins and their known binding partners, which we previously detected in
immunoprecipitation experiments against BRP22, were suppressed by
RNA interference (RNAi) restricted to presynaptic motor neurons. RNAi-induced
presynaptic knockdown of the only Drosophila homologue of the
Neurabin/Spn family caused an increase of AZ numbers at the NMJ (Fig. 1a; Supplementary Fig.
1a–e). Simultaneously, the total area of postsynaptic GluRs
increased (Supplementary Fig.
1b–e).
Figure 1
Characterization of the Drosophila
spn locus.
(a) Domain structure of Spn: protein phosphatase 1 (PP1) binding
motif, PDZ domain, coiled coil (CC) domain and sterile alpha motif (SAM)
domain. (b) Organization of the spn locus. Transposon lines
used in the generation of Spn mutants, positions covered by the
Pacman constructs indicated on a genomic map of Spn. (c)
Immunostaining with Spn antibody (green) and HRP antibody (blue) at control
NMJs, (d) at Spn null NMJs (e) and Spn null NMJs
with a genomic rescue construct. (f) Presynaptic knockdown of Spn
leaves the HRP boundaries devoid of Spn protein. (g) Postsynaptic
knockdown of Spn using a muscle driver line reveals discrete clusters of Spn
within the presynaptic terminals. (h) Presynaptic co-labelling of
GFPSpn together and BRP D3strawberry using
a motor neuron driver. Scale bars, 10 μm;
2 μm in magnified images.
Motivated by this result, we generated a Spn null allele using
Flippase-mediated trans-deletion of FRT sites with two transposon lines flanking
the spn locus, resulting in a complete deletion of the Spn-encoding
sequence (spn) (Fig.
1b). Genomic PCR23 was used to validate the
elimination of the entire spn locus. Animals died in pupal stages when we
put the spnΔ3.1 chromosome in trans to a large
deficiency (spn/dfBSc116, from
hereafter Spn). Neurabin/Spn family proteins in rodents are strongly
expressed in postsynaptic spines2425 and are also found in
presynaptic compartments2627. Our presynaptic Spn knockdown
clearly affected AZ scaffold formation, pointing towards a presynaptic role for
Spn at Drosophila NMJs. To validate this hypothesis, and to determine Spn
localization, we raised a polyclonal antibody against a fusion protein from the
Spn N-terminal region (Anti-SpnNterm, Fig.
1a; green bar). The Spn antibody robustly stained wild-type NMJs, but
the signal was lost in Spn mutant larvae (Fig.
1c,d). Staining was restored after crossing in a genomic Spn rescue
construct (Pac(Spn1)), proving the specificity of the NMJ Spn
antibody signal (Fig. 1e). To characterize the
localization of endogenous Spn in pre- versus postsynaptic compartments, we
expressed the Spn-RNAi transgene in either the pre- or postsynaptic compartment
of the NMJ using specific Gal4-driver lines. Motoneuron-driven presynaptic RNAi
left the anti-Spn staining intact at the bouton periphery, but removed the
staining within the horseradish peroxidase (HRP) signal, which outlines
the neuronal membrane (Fig. 1f). Muscle-driven
postsynaptic RNAi made the Spn staining surrounding the boutons vanish. However,
the signal inside the presynaptic boutons (Fig. 1g)
remained unchanged. When a GFPSpn fusion construct was
co-expressed with the AZ marker BRP-D3Straw within the
motoneurons21, presynaptic Spn formed discrete clusters,
often found adjacent to BRP-labelled AZ scaffolds (Fig.
1g,h). This pattern was very similar to the residual endogenous Spn
staining found remaining after the expression of RNAi in the postsynaptic muscle
(Fig. 1g). Thus, Spn localizes to both pre- and
postsynaptic compartments at larval NMJs. Presynaptic Spn localizes close to
presynaptic AZ scaffolds.Subsequently, we analysed the role of Spn in synaptic organization at developing
NMJs, using the null allele (Spn) we created (Fig.
1b). Detailed analysis of Spn NMJs revealed that AZ scaffold
densities increased. Postsynaptic GluR (GluRIID) labelling28 was
also strikingly increased (Fig. 2a,b). We expressed two
different but overlapping genomic pacman transgenes29 containing
the full spn locus (Pac(Spn1&2); Fig. 1b) in the null allele mutant background to prove the
specificity of the Spn null phenotype. Both genomic constructs fully
rescued adult viability and, importantly, the NMJ phenotypes of Spn. In
addition, deletion of a stretch encoding the Spn open reading frame within the
genomic construct of Pac(Spn2), named Pac(Spn*),
abolished rescue activity (data not shown). We further tested a semi-lethal
transposon insertion within the spn locus
(Mi(Mic)SpnMI06873), which we found to significantly reduce
anti-Spn staining. The latter mutant showed NMJ phenotypes similar, but somewhat
weaker, than those observed in Spn null larvae (Supplementary Fig. 2a–e). Taken
together, we show that loss of Spn affects the synaptic structure of the NMJ. We
quantified relevant structural parameters using BRP/GluRIID/HRP co-stainings to
further characterize this phenotype (Fig. 2d–g).
Average NMJ size (visualized via HRP) was not significantly changed in the
Spn null background. Similarly, but more pronounced than in the RNAi
experiments, the densities of presynaptic AZs (BRP cluster numbers normalized to
synaptic HRP area) were significantly increased in Spn when compared with
controls (Fig. 2d,e). We re-expressed the protein using a
neuronal driver line elav(x)-C155-gal4 in the Spn null background
to test whether this was due to a loss of presynaptic Spn. Indeed, presynaptic
expression of Spn complementary DNA (cDNA) effectively re-established normal AZ
densities (Fig. 2c–e). By contrast, postsynaptic
(that is, muscle) expression of Spn in the null background appeared to have no
effect (data not shown). Moreover, the postsynaptic phenotype of increased GluR
fields was reverted towards normal levels on presynaptic Spn expression (Fig. 2f). Thus, presynaptic Spn restricts both the
dimensions of the PSD, as well as the number of juxtaposed presynaptic BRP
scaffolds. The BRP scaffold is tightly associated with
Ca2+ channels and RBP, another structural component
of the AZ scaffold30. Numbers of Ca2+
channel clusters and RBP clusters were also increased at Spn terminals
(Supplementary Fig.
3a–f). By contrast, cysteine string protein, a SV protein,
appeared unchanged when compared with controls (Supplementary Fig. 3d–h). Taken
together, these data show that Spn terminals have a specific increase in
the number of AZ scaffolds.
Figure 2
Presynaptic Spn limits NMJ AZ numbers.
(a–c) Projected confocal stacks of NMJs (muscle 4),
labelled against BRP (BRPNc82, green) and GluRIID (magenta).
(d) NMJ sizes measured using HRP labelling. (e) Numbers of
AZ scaffolds per NMJ measured using BRPNc82 labelling (Ctrl:
324.8±16.29, n=14; Spn:
440.5±28.4 n=13; neuronal WTSpn
cDNA expression (WTrescue): 348.4±17.45,
n=14; Ctrl versus Spn P<0.01,
(U=25); Ctrl versus WTrescue:
P>0.05, (U=79); Spn versus
WTrescue: P<0.05,
(U=38)). (f) AZ scaffold densities (spots per
μm2): WTSpn cDNA expression
(Ctrl: 1.5±0.04, n=14; Spn:
1.97±0.08, n=13; WTrescue:
1.65±0.6, n=14; Ctrl versus Spn
P<0.001, (U=13); Ctrl versus
WTSpn rescue: P>0.05;
(U=57); Spn versus WTrescue:
P<0.01, (U=36)). (g) Integrated
GluRIID intensity is higher in Spn (Ctrl: 100±7.6,
n=14; Spn: 147.1±10.74,
n=13; WTrescue: 117.6±7.6,
n=14; Ctrl versus Spn: P<0.01,
(U=31); Ctrl versus WTrescue:
P>0.05, (U=65); Spn versus
WTrescue: P<0.05, (U=53).
All tests are Mann–Whitney U-test, values are
mean±s.e.m., NS, not significant; *P≤0.05;
**P≤0.01;
***P≤0.001. Scale bar, 10 or
1.5 μm in magnified images.
AZ scaffolds lacking Spn remain small
Confocal images suggested that individual presynaptic AZ scaffolds, as identified
by their BRP spots, were atypically small at Spn terminals. However,
confocal resolution (∼250 nm) is not sufficient to reliably
quantify AZ scaffold size. Thus, we turned to stimulated emission depletion
(STED) microscopy operating with ≈45 nm lateral
resolution2131 to visualize AZ scaffolds in their planar
orientation (Fig. 3a–c). Analysing the longest
peak-to-peak axes through individual AZs revealed that the diameters of BRP AZ
scaffolds were substantially reduced in Spn mutants, while presynaptic
Spn re-expression restored normal AZ size (Fig.
3a–e).
Figure 3
Ultrastructural analyses of
NMJ synapses.
(a–c) STED-derived BRP rings are atypically small in
Spn terminals. (d,e) Quantification of BRP ring
diameters. Control: 227.5±4 nm,
n=168; Spn: 160.8±2 nm,
n=178; WTrescue:
216.3±3.9 nm, n=156;
Kruskal–Wallis test with Dunn's multiple comparison test
(K=186). *P≤0.05;
**P≤0.01;
***P≤0.001. Error bars:
mean±s.e.m. (f,h) Electron microscopy of
presynaptic electron-dense projections (T-bars) of (f) control
boutons, (g) Spn boutons with more, but smaller T-bars; the
Spn phenotype which can be rescued by presynaptic re-expression
of Spn (h). Arrowheads indicate the edges of T-bars platforms.
(i,j) Structured Illumination (SIM) analysis of WT and
Spn NMJs. Co-labelling of GluRIID and BRPNc82 for
wild-type (i) and Spn (j) NMJs show excessive
accumulations of GluRs at Spn NMJs with arrays of small BRP scaffolds
converging on enlarged GluR fields. (k,l) 3D rendering of SIM
images shown above. Scale bars: STED, 200 nm; EM,
100 nm; SIM, 2 μm.
In summary, a larger number of smaller presynaptic AZ scaffolds are forming in
the absence of presynaptic Spn. Electron microscopic (EM) analysis consistently
revealed smaller but otherwise normal T-bars (Fig. 3f,h,
arrowheads; Supplementary Fig.
4a–e). In some cases, two of these small T-bars converged
(juxtaposed) into one common large postsynaptic compartment, identified by a
region in which pre- and postsynaptic membranes were tightly apposed (Fig. 3g).GluRs at wild-type NMJ synapses localize at postsynaptic membranes opposed to
presynaptic AZs. As mentioned above (Fig. 2), individual
GluR clusters were atypically enlarged in Spn. As details of the GluR
organization may not be resolved by standard confocal imaging, we used
three-dimensional structured illumination microscopy (3D SIM) with an isotropic
resolution of ≈120 nm32. This provides a
significant improvement in optical resolution along the z-axis, while
STED only increases the x–y resolution. Therefore, SIM allowed
us to resolve the 3D organization of GluR fields relative to the AZs. Consistent
with the EM analysis, Spn NMJs showed extended, often continuous receptor
fields, juxtaposed to several small AZs, with a clear increase in the area of
the postsynaptic compartment labelled with GluRs (Fig.
3i–l).
Increased Nrx-1 signalling mediates the Spn phenotype
PSDs of Drosophila NMJs contain two subtypes of GluR complexes,
distinguished by the incorporation of either receptor subunit GluRIIA or
GluRIIB28. Immature wild-type PSDs contain more GluRIIA than
IIB, while GluRIIB incorporation occurs during subsequent PSD maturation,
revealed by in vivo imaging33. We recently discovered that
Nlg1, Nrx-1 and Syd-1 mutants share a specific deficit
in the incorporation of GluRIIA receptors into the PSD driving
‘early' PSD growth13. In contrast, here we
observed a threefold increase of GluRIIA intensity at Spn terminals,
probably responsible for the overgrowth of the postsynaptic GluR fields, while
GluRIIB levels remained unchanged (Supplementary Fig. 5a–e). Thus, lack of Spn apparently
results in an opposite phenotype to Nrx-1 signalling pathway mutants
(Nrx-1, Nlg1, Syd-1), which show fewer but larger and often
mis-shapen AZ scaffolds131516. To further investigate a
possible antagonistic relationship between Spn and Nrx-1/Nlg1, we investigated
whether Nrx-1 levels were changed at Spn terminals, using an antibody
detecting endogenous Nrx-1 (ref. 15). We observed a
significant increase in the levels of Nrx-1 (measured either as the total
integrated fluorescence from the anti-Nrx-1 label, or total area of Nrx-1
clusters normalized to synaptic HRP area; Fig.
4a–d). We next asked whether this increase in Nrx-1 could
promote Nrx-1 signalling. To test this, we first evaluated the levels of Nlg1
and Syd-1 in Spn mutants. We found that the level of both proteins
increased at Spn NMJs (Fig. 4e–h; Supplementary Fig. 6a–g).
However, Fasciclin-II (another cell adhesion molecule unrelated to the
Nrx-1/Nlg1 signalling pathway34) was unchanged (Supplementary Fig. 7a,b). Next, to confirm
that Nrx-1 signalling is directly responsible for the generation of more AZs at
Spn terminals, a single copy of the nrx-1 gene (allele
Nrx-1; ref. 15) was removed from the Spn background. This manipulation
in wild type background had no detectable effect on NMJ and AZ organization
(ref. 15; data not shown). Strikingly, AZ numbers
were reduced to wild type levels after removing a single nrx-1 gene copy
from the Spn background (Fig. 4i–l). The
AZ assembly and maturation mediated by Nrx-1 depends on both muscle expressed
(postsynaptic) Nlg1 (refs 11, 35) and presynaptic Syd-1. In fact, removing a single nlg1
gene copy in Spn null background (nlg;
ref. 11) suppressed the Spn phenotype (Fig. 4m–p). Furthermore, removing a single gene
copy of syd-1 also suppressed the Spn phenotype (Fig. 4q–t). We went on to analyse the functional
relationship between Spn and Syd-1; both are presynaptically expressed scaffold
proteins containing a PDZ domain.
Figure 4
Spn regulates trans-synaptic signalling.
All mutant tests Mann–Whitney U-test, values are
mean±s.e.m., NS, not significant; *P≤0.05;
**P≤0.01;
***P≤0.001.
(a–d) Upregulation of Nrx-1 levels at Spn
mutant NMJs. (a,b) Muscle 4 NMJs of wild-type and Spn
larvae immunostained for Nrx-1. (c,d) Quantification of Nrx-1
signals. Total Nrx-1 covered area (a.u.): wild type 100±19.63,
n=19; Spn 150.7±16.6,
n=19; wild type versus Spn P<0.05,
(U=92); Nrx-1 intensity (a.u.): wild type
100±14.12, n=19; Spn:
117.5±7.6, n=19; wild type versus Spn,
P<0.05, U=108.
(e–h) Upregulation of Nlg1 levels at Spn
NMJs. (e,f) Wild type and Spn larvae immunostained for
Nlg1. (g,h) Quantifications of Nlg1 signals. Total Nlg1
covered area (a.u.). Wild type 100±13.21, n=19;
Spn 257±27, n=19; wild type versus
Spn P<0.001, (U=42). Nlg1 intensities
(a.u.): wild type 100±8.3, n=19; Spn:
166.7±9.8, n=19; wild type versus Spn,
P<0.001, (U=33).
(i–t) Genetic interaction analysis of Spn
phenotypes. (i–l) Genetic suppression of Spn
phenotypes by Nrx-1 (i–k). NMJs immunostained for
BRPNc82 and GluRIID. (l) Quantification of BRP
spot densities at NMJs. Wild type 100±5, n=11;
Spn 132.7±3.8, n=12;
Nrx-1/+, Spn:
108.9±3.1; wild type versus Spn, P<0.001,
(U=10); wild type versus
Nrx-1/+, Spn,
P>0.05, (U=50); Spn versus
Nrx-1/+, Spn,
P<0.001, (U=17).
(m–p) Genetic suppression of Spn
phenotype by Nlg1; (p) Quantification of BRP spot densities. Wild
type 100±3.1, n=10; Spn
132.9±3.7, n=11;
Nlg1/+, Spn
108.1±6; wild type versus Spn, P<0.001,
(U=3); wild type versus
Nlg1/+, Spn,
P>0.05, (U=37); Spn versus
Nlg1/+, Spn,
P<0.01, (U=20).
(q–t) Genetic suppression by Syd-1. (t)
wild type: 100±3, n=10; Spn:
135.1±4.6, n=13;
Syd-1/+, Spn:
103.7±5; wild type versus Spn, P<0.001;
(U=4). Wild type versus
Syd-1/+, Spn
P>0.05; (U=57). Spn versus
Syd-1/+, Spn,
P<0.001; (U=21). Scale bars,
10 μm.
Antagonism of Spn and Syd-1 for Nrx-mediated synapse assembly
We previously found that Nrx-1 levels are decreased in Syd-1 mutants, but
stabilized on re-expression of Syd-1. Moreover, previous fluorescence recovery
after photobleaching (FRAP) analysis showed elevated mobility of
Nrx-1GFP in a Syd-1 mutant background13. As Nrx-1 and Syd-1 clusters in Spn were upregulated (Fig. 4a–d;Supplementary Fig. 6a–g), we asked whether it was possible
that the motility of Nrx-1 was altered in Spn mutants by performing FRAP
experiments on Nrx-1GFP. We found a delayed recovery and, thus,
reduced motility of Nrx-1 in the Spn null background (Supplementary Fig. 6i–l). At the
same time, lack of DrosophilaCASK (Caki), another scaffolding protein
that binds to the Nrx-1 C terminus3637, did not show any
noticeable effect on Nrx-1 motility (Supplementary Fig. 6). Moreover, the recovery of
Syd-1GFP clusters appeared to be unchanged at Spn
terminals (even though the cluster density was increased) (Supplementary Fig. 6i–k). Thus,
Spn-mediated Nrx-1 motility is apparently not connected to altered Syd-1
motility.We further investigated whether, as suggested by the Nrx-1 FRAP data, Syd-1 and
Spn would operate in a competitive manner. Consequently, we revisited our
previous finding that overexpression of Syd-1 within motoneurons results in
co-expressed Nrx-1GFP being recruited into AZs13.
However, when Spn was also co-overexpressed with Nrx-1GFP and
mStrawberrySyd-1, both the Nrx-1GFP level and
mStrawberrySyd-1 level at AZs dropped (Nrx1GFP
intensity in wild-type background: 1.0±0.06, n=20;
Nrx1GFP intensity in the presence of overexpressed Spn:
0.8±0.04, n=19; P<0.01;
Mann–Whitney t-test (U=113).
mStrawSyd-1 intensity in wild-type background:
1.0±0.04, n=20; mStrawSyd-1
intensity in the presence of Spn: 0.76±0.05; P<0.01;
Mann–Whitney t-test (U=75)). Thus, Spn
gain-of-function might influence Nrx-1, antagonistic to the Spn loss-of-function
phenotype (Fig. 4b; Supplementary Fig. 6a–g). In fact, AZ sizes on Spn
overexpression were slightly (but significantly) increased over controls (Ctrl:
222±3, n=108; GFPSpn:
246±4.5, n=160; ctrl versus
Spn OE P<0.001; Student's
t-test).
The Spn-PDZ domain interacts with Nrx-1 C terminus
We performed immunoprecipitation experiments from Drosophila head
extracts22, using antibodies against Nrx-1 (refs 13, 15), to test whether
Spn and Nrx-1 might be part of a common complex. Western blot analysis with the
anti-Spn antibody specifically detected bands in the range of
∼200 kD, validating the specificity of our custom-made
anti-Spn antibodies (Fig. 5a; upper panel). Using Nrx-1
antibodies, which robustly immunoprecipitated Nrx-1 (Fig.
5a; middle panel), Spn could be co-immunoprecipitated, but was absent
in negative controls which used an irrelevant IgG (Fig.
5a; lower panel). We performed a yeast two-hybrid (Y2H) analysis using a
C-terminal fragment of Nrx-1 to screen against different fragments of Spn to
investigate a direct Nrx-1/Spn interaction (Fig. 5b,c). As
a control, we included a Syd-1 fragment, which we had previously shown to
interact with Nrx-1 (ref. 13). Semiquantitative Y2H
analysis uncovered a strong and specific interaction between the cytosolic part
of Nrx-1 (hereafter termed Nrx-1 C-term) and a 500 amino acid region of Spn
containing the PDZ domain (Spn-F3) (Spn-F3 × Nrx-1 C-term in Fig. 5c). The fact that the overlapping constructs F2 and F4
(Fig. 5b) did not show any interaction narrowed down
the possible interacting stretch to a region comprising only the PP1 and the PDZ
domains. These domains are present in all Spn family members and are highly
conserved between fly, worm and rodent (Supplementary Fig. 8a). The Nrx-1 C-term/Spn-F3 interaction was
eliminated after deleting the last five amino acids of the Nrx-1 C terminus. In
addition, introduction of a point mutation38 in the Spn-PDZ
domain (in the ligand-binding pocket) which abolishes ligand binding, also
abolished the interaction (Fig. 5c). Thus, the very
C-terminal PDZ-binding motif of Nrx-1 interacts directly with PDZ domains found
in both Spn and Syd-1. To characterize the binding of Nrx-1 C-term to the
Spn-PDZ domain at atomic resolution, we turned to X-ray crystallography. We
solved the structure of PDZ domain containing residues 1,258–1,347 of
Spn in complex with the last 10 C-terminal residues of Nrx-1 (at 1.2 A°
resolution) (Fig. 5d; Supplementary Fig. 8; Supplementary Table 1). The Spn-PDZ domain
shares the characteristic canonical fold of PDZ domains, which is composed of
six β-strands and two α-helices39. According
to its specificity for C-terminal peptides, Spn-PDZ is a class II PDZ domain,
recognizing the signature motif
X–Ψ–X–Ψ (X, unspecified; and
Ψ, hydrophobic amino acid residue). We found the peptide-binding groove
to be flanked by a β-strand (β2) and an α-helix
(α2). The Nrx-1 peptide binds in an anti-parallel mode, with main
chain/main chain hydrogen bonding to β2 of the Spn-PDZ. The carboxylate
of the Nrx-1 peptide is hydrogen bonded to backbone amides of L1271 and L1273 in
Spn-PDZ (Fig. 5d;Supplementary Table 2). Further interactions are established with the
side chains of Spn-PDZ residues residing on β4 and α2 (Fig. 5d). In addition, we observed an inter-peptide
interaction that might be important for stabilizing the peptide conformation. We
investigated the binding thermodynamics of the Nrx-1 C-term peptide to the PDZ
domains of Spn or Syd-1 using isothermal calorimetry (ITC). The Syd-1-PDZ domain
showed higher affinity binding (Kd 5 μM) than the Spn-PDZ
domain (50 μM) (Supplementary Fig. 8e,f). Both Spn-PDZ domains and Nrx-1 C-termini
are highly conserved between Drosophila and rodents (Supplementary Fig. 8a,c). In fact, an in
vitro pull-down experiment effectively precipitated both the
DrosophilaSpn-PDZ and ratSpn-PDZ using the respective Nrx-1
peptides (Supplementary Fig. 9a).
To validate an in vivo interaction between Spn and Nrxs in rodents, we
performed co-immunoprecipitation experiments from mouse whole brain lysates
using a newly generated affinity-purified pan-Nrx antibody (Supplementary Fig. 9b). We analysed the
co-imunoprecipitated proteins by mass spectrometry. Nlg, Spn and several
additional synaptic PDZ-domain-containing proteins known to interact with Nrxs
could be detected in the Nrx immunoprecipitates, but not in precipitations with
control IgGs (Fig. 5e). The presence of Spn/Nrx complexes
was further confirmed by western blotting of the precipitates (Fig. 5f). Thus, we find that Spn/Nrx interactions show evolutionary
conservation fully consistent with their shared sequence conservation.
Figure 5
Spn interacts directly with the Nrx-1 C-term.
(a) Western blot analysis of larval head extracts from wild type,
Spn and pan-neuronal elav(x)-c155-gal4 driven Spn-RNAi
show the specificity of our custom anti-SpnNterm antibody.
Immunoblot of Nrx-1 immunoprecipitate (IP) from a Drosophila head
fractionation enriched for AZ proteins (Methods). Spn can be detected using
a Nrx-1 Co-immunoprecipitation (co-IP), but is absent when a control
immunoglobulin G is used (IgG). (b) Domain structures of Nrx-1, Syd-1
and Spn. Nrx-1 possesses extracellular laminin G (LAM G) and epidermal
growth factor (EGF)-3 domains, as well as a PDZ binding motif at the C
terminus. Syd-1 comprises an N-terminally located PDZ domain, a C2 domain
and a putative RhoGAP domain. Spn domain structure and the boundaries of
fragments used in Y2H experiments (F1-F5) (Supplementary Fig. 7). (c)
Quantitative liquid Y2H assay for binding of individual Spn fragments (and
Syd-1 F1) with the Nrx-1 C terminus. Fragment 3, containing the PDZ domain,
binds strongly to the Nrx1 C-term. Binding is fully abolished when a point
mutation is introduced into the ligand-binding site of the Spn-PDZ domain,
or when the last five amino acid residues of the Nrx-1 C-term (Nrx-1
c-term*) are deleted. (d) A structural representation of the
Spn-PDZ interacting with the Nrx-1 C-term peptide. The C-terminal Nrx
peptide is shown in grey using a stick representation. Residues on Spn-PDZ
that interact with the Nrx peptide are highlighted in black. Red dashed
lines indicate potential hydrogen, bonds with a distance cut-off of
≤3.3 Å. (e) Mass-spectometric analysis of
protein complexes immunoprecipitated from mouse whole brain homogenate using
Nrx-1 antibody. (f) Western blot analysis showing the Nrx antibody
effectively co-IPs Spn (see Supplementary Fig. 12).
PDZ domain ligand binding of Spn controls AZ structure and
function
If binding of the Spn-PDZ domain to Nrx-1 was, in fact, functionally relevant,
introducing the point mutation1338 that interferes with Nrx-1
binding in vitro should compromise Spn function in vivo. Indeed,
expression of the Spn cDNA containing the relevant point mutation
(PDZ*Spn) no longer rescued the structural
presynaptic AZ phenotype of Spn mutants. As expected, expression of
wild-type cDNA (WTSpn; Fig. 2c) rescued the
phenotype (Fig. 6a–e). Thus, interfering with
ligand binding to the Spn-PDZ domain renders the protein incapable of limiting
AZ numbers.
Figure 6
Electrophysiological characterization of
NMJs.
(a–d) BRPNc82 labelling in indicated
genotypes. (e) Quantification of BRP spot densities in
a–d, Ctrl: 100±4.6,
n=6; Spn: 126.1±2.08,
n=8; WTrescue: 104.5±2.6,
n=8; rescue:
137.8±4.45, n=7. Ctrl versus Spn
P<0.001, (U=2). Spn versus
WTrescue P<0.001,
(U=0.0). WTrescue versus
rescue P<0.001,
(U=0). (f) Representative mEJCs traces.
(g) Representative eEJCs traces. (h) Paired-pulse
measurements with inter stimulus interval (ISI) of 10 ms;
(i) Quantification of mEJC frequencies (Ctrl:
2.02±0.16, n=28; Spn:
3.33±0.34, n=15, P<0.01;
WTrescue: 2.32±0.26,
n=16, P>0.05;
PDZ*rescue: 3.16±0.36,
n=16, P<0.05. (j) Quantification of
mEJC amplitudes (Ctrl: −0.78±0.03 nA,
n=28; Spn:
−0.96±0.05 nA, n=15,
P<0.01; WTrescue:
−0.80±0.02 nA, n=16,
P>0.05; PDZ*rescue:
−0.86±0.03 nA, n=15,
P>0.05). (k) Quantification of eEJC amplitudes
(Ctrl: −80.23±4.66 nA,
n=28; Spn:
−55.00±3.29 nA, n=24,
P<0.01; WTrescue:
−82.58±6.0 nA, n=18,
P>0.05; PDZ*rescue:
−38.66±3.67, n=18,
P<0.01). (l) Quantification of quantal content (Ctrl:
101.4±5.89, n=28; Spn:
57.20±3.42, n=24, P<0.001;
WTrescue: 103.0±7.53, n=18,
P>0.05; PDZ*rescue:
45.13±4.29, n=18, P<0.001).
(m) Quantification of the pair pulse ratio with an ISI of
10 ms. (Ctrl: 0.90±0.05, n=28;
Spn: 1.26±0.09, n=22;
P<0.01; WTrescue: 1.01±0.08,
n=18, P>0.05;
PDZ*rescue: 1.36±0.09,
n=18, P<0.001). (n) Quantification of
the paired-pulse ratio with a 30 ms ISI (Ctrl: 1.08
±0.04, n=28; Spn: 1.37±0.06,
n=21, P<0.01; WTrescue:
1.28±0.05, n=18, P>0.05;
PDZ*rescue: 1.44±0.08,
n=17, P<0.001). Statistics: one-way analysis
of variance with Tukey's multiple comparison post test. All panels
show mean±s.e.m., NS, not significant;
*P≤0.05; **P≤0.01;
***P≤0.001. Scale bars:
a–d, 10 μm; f,
1 nA/1 s; g,h,
20 nA/20 ms.
Finally, we investigated the physiological consequences of presynaptic Spn loss.
We performed two-electrode voltage-clamp recordings (TEVC) to assay SV release.
We observed a clear increase in the frequency of spontaneous SV release from
Spn terminals, which dropped to normal rates when normal
(WTSpn) was re-expressed in the presynaptic motoneuron (Fig. 6f,i). However, on expression of
PDZ*Spn under identical conditions, the frequencies
of spontaneous release events remained high (Fig. 6f,i).
The amplitudes of single spontaneous release events were significantly larger at
Spn terminals (Fig. 6j), potentially reflecting
the larger postsynaptic GluRIIA receptor fields described above (Fig. 2b; Supplementary Fig.
5; Fig. 3i–l). In contrast, release
evoked by single action potentials was clearly decreased at Spn NMJs
(Fig. 6g,k). Loss of Spn also altered synaptic
short-term plasticity, in response to stimulation with a pair of action
potentials (at 10- or 30-ms intervals). Here Spn NMJs displayed abnormal
facilitation (Fig. 6h,m,n). Both defects were rescued by
the presynaptic expression of WTSpn, while expression of the
PDZ*Spn again did not rescue. Altogether, these results suggest that Spn
is not only responsible for the functional distribution of presynaptic AZ
scaffolds but also plays an important role in SV release, and that the reduced
evoked responses were not due to decreased postsynaptic sensitivity. In
addition, a higher number of presynaptic AZs, as observed in Spn
terminals, is in line with an increased number of spontaneous release events
detected. However, the fact that evoked release is lowered is unexpected,
raising the question of whether the additional AZs observed in Spn are
sub-optimal for evoked release, but can maintain spontaneous release. To answer
this question, we went on to investigate the function of Spn at the single AZ
level.
Spinophilin optimizes evoked release at single synapses
The TEVC recordings sample release events over the whole NMJ of the respective
muscle, but do not allow for the analysis of individual AZs. To investigate the
latter, we used a recently developed assay employing post-synaptically expressed
GCaMP to characterize the spatial and temporal dynamics of exocytotic
events2340. We imaged GCaMP responses to spontaneous
exocytosis for 100 s (see Supplementary Movies 1 and 2 for examples) and, subsequently GCaMP
response to action potential stimulation (35 action potentials given at
0.2 Hz, see Supplementary
Movies 3 and 4 for examples). After recordings, larvae were fixed,
stained against BRP and visualized using confocal microscopy. Alignment of these
confocal images to the live movies (Supplementary Fig. 10; see methods for further details) allowed us to
map activity at individual AZs (Fig. 7). Strikingly,
spontaneous activity per AZ was not changed at Spn NMJs, suggesting that
the net increase of spontaneous events observed in TEVC experiments is, indeed,
due to an increase in synapse number rather than in their individual release
rates (Fig. 7a,c). By contrast, the probability of evoked
exocytosis was drastically reduced (Fig. 7b,d). However,
the individual evoked GCaMP signals were indistinguishable between Spn
and control NMJs (Fig. 7d). Consistent with our TEVC
results, we found that loss of Spn changed the partitioning of AZs between these
two discrete release modes: the fraction of AZs dedicated to evoked release was
significantly reduced in Spn (Fig. 7e). Therefore,
we conclude that even though Spn-deficient synapses participate in both modes of
SV release, Spn is essential for establishing correct synaptic release
probability, in agreement with the altered short-term plasticity we observed in
our TEVC experiments (Fig. 6k–n). It was found
recently that release probability at individual AZs correlated with the local
levels of BRP240 which, as mentioned above, is reduced at
Spn synapses (Fig. 3). Is the decrease in
release probability at Spn synapses due to a reduction in their BRP
levels? To address this question, we investigated the relationship between
synaptic BRP and the number of release events evoked at single AZs2. We found that release probability was indeed positively correlated with BRP
levels (Fig. 7f). Furthermore, the average number of
release events evoked at Spn synapses also (but somewhat weaker)
correlated with BRP level. However, as this relationship differed from that
observed in control animals we can rule out the possibility that the effect is
mediated solely through BRP reduction. Thus, we conclude that Spn is not only
important for controlling synapse number and size, but also for optimizing
action-potential-induced exocytosis by enhancing release probability at
individual AZs.
Figure 7
Individual
AZs show normal spontaneous release, but lower probabilities for action
potential-induced (evoked) release.
(a,b) Synaptic activity at control and Spn NMJs was
first imaged for 100 s without stimulation. Subsequently,
exocytosis was stimulated by 35 action potentials at 0.2 Hz.
Images are montages of NMJ confocal scans showing staining for
BRPNc82. Spontaneous and evoked activities indicated by
magenta and cyan circles, sizes reflect the number of events per AZ.
(c) Local average postsynaptic GCaMP5 signals at Spn and
control AZs in response to spontaneous release events (left traces).
Frequencies of spontaneous (‘mini') events per AZ in
Spn and controls very similar (centre bar graph), as is the
fraction of AZs participating at least once in spontaneous activity (right
bar graph). (d) Evoked release causes similar postsynaptic GCaMP5
signals at individual Spn and control AZs (left traces). The
probability that an AZ shows release in response to a single action
potential (pr) significantly reduced in Spn compared with controls
(centre bar graph). The fraction of AZs responding at least once to
stimulation also significantly reduced in Spn mutants AZs (right bar
graph). (e) Categorization of AZs based on their activity pattern:
(1) AZs exclusively active during spontaneous release (spont. only), (2) AZs
exclusively responsive to AP-stimulation (evoked only), (3) AZs releasing
both modes at least once (mixed) or (4) AZs not responding (silent). The
fraction of 'evoked only‘ AZs was significantly reduced
at Spn NMJs. (f) Reduced pr at Spn AZs is not secondary
to lower BRP levels. AZs were binned with regard to their local BRP
intensity and the average number of evoked events was plotted against the
average BRP intensities (Supplementary Information File). Evoked events per AZ were
correlated to local BRP levels in controls (black data points: experimental
data, black line: linear fit, reduced
r2=0.92) and, to a lesser extent, at
Spn AZs (red data points: experimental data, red line: linear
fit, reduced r2=0.69). Loss of Spn reduced
evoked release more than expected by a mere reduction of BRP and both
dependencies were best fit by different lines (F-test,
P<0.05). Values are mean±s.e.m. Vertical/horizontal
scale bars in c,d: 100 a.u./200 ms. Number of
animals (n): Control: n=5, Spn:
n=4. *P<0.05 in
Mann–Whitney U-test.
Discussion
The trans-synaptic dialogue between Nrx-1 and Nlg1 aids in the initial assembly,
specification and maturation of synapses, and is a key component in the modification
of neuronal networks124142. Regulatory factors and processes that
fine-tune and coordinate Nrx-1/Nlg1 signalling during synapse assembly process are
currently under investigation. Our data indicate that DrosophilaSpn-like
protein acts presynaptically to attenuate Nrx-1/Nlg1 signalling and protects from
excessive seeding of new AZ scaffolds at the NMJ. In Spn mutants, excessive
AZs suffered from insufficient evoked release, which may be partly explained by
their reduced size, and partly by a genuine functional role of Spn (potentially
mediated via Nrx-1 binding).In mice, loss of Spn (Neurabin II), one of the two Neurabin protein families present
in mammals, was reported to provoke a developmental increase in synapse numbers43. While Spinophilin was found to be expressed both pre- and
post-synaptically2627, its function, so far, has only been
analysed in the context of postsynaptic spines43444546. Given
the conserved Spn/Nrx-1 interaction we report (Fig. 5), Spn
family proteins might execute a generic function in controlling Nrx-1/Nlg1-dependent
signalling during synapse assembly. We consistently find that Spn counteracts
another multi-domain synaptic regulator, Syd-1, in the control of Nrx-1/Nlg1
signalling. Previous genetic work in C. elegans identified roles of Syd-1
epistatic to Syd-2/Liprin-α in synaptogenesis547. Syd-1
also operates epistatic to Syd-2/Liprin-α at Drosophila NMJs1748. Syd-1 immobilizes Nrx-1 (ref. 13),
positioning Nlg1 at juxtaposed postsynaptic sites, where it is needed for efficient
incorporation of GluR complexes. Intravital imaging suggested an early checkpoint
for synapse assembly, involving Syd-1, Nrx-1/Nlg1 signalling and oligomerization of
Liprin-α in the formation of an early nucleation lattice4950, which is followed later by ELKS/BRP-dependent scaffolding
events2151 (our model in Fig. 8, upper
panel). As Spn promotes the diffusional motility of Nrx-1 over the terminal surface
and limits Nrx-1/Nlg1 signalling, and as its phenotype is reversed by loss of a
single gene copy of nrx-1, nlg1 or syd-1, Spn displays all the
features of a ‘negative' element mounting, which effectively
sets the threshold for AZ assembly. As suggested by our FRAP experiments (Supplementary Fig. 6), Spn might
withdraw a population of Nrx-1 from the early assembly process, establishing an
assembly threshold that ensures a ‘typical' AZ design and
associated postsynaptic compartments (Fig. 8). As a negative
regulatory element, Spn might allow tuning of presynaptic AZ scaffold size and
function (see below).
Figure 8
Model describing the role of Spn in controlling the synaptogenic activity of
Nrx-1 at
NMJs.
Spn acts antagonistically to Syd-1. In wild-type animals (upper panel), Nrx-1
interacts with postsynaptic Nlg1, as well as with either Syd-1 or Spn via
PDZ domain-mediated interactions. In this way, trans-synaptic contact with
Nlg1 can also steer postsynaptic assembly. The presence of Spn reduces the
amount of Nrx-1 available for Syd-1 binding and, consequently, controls the
number of AZs, by keeping the availability of critical proteins (BRP) below
an assembly threshold. In addition, Nlg1-mediated postsynaptic assembly is
also affected (not shown). In the absence of Spn (lower panel), Nrx-1 is
less mobile and more efficiently recruited into complexes by Syd-1,
resulting in the formation of excessive presynaptic AZ scaffolds.
The C. elegansSpn homologue NAB-1 (NeurABin1) was previously shown to
bind Syd-1 in cell culture recruitment assays52. We found consistent
evidence for Syd-1/Nrx-1/Spn tripartite complexes in salivary gland experiments
(Supplementary Fig. 11). Moreover,
the PDZ domain containing regions of Spn and Syd-1 interacted in Y2H experiments
(Fig. 5c). It would be interesting to dissect whether the
interaction of Spn/Syd-1 plays a role in controlling the access of Nrx-1 to one or
both factors. For C. elegans HSN synapses, a previous study52
showed that loss of NAB-1 results in a deficit of synaptic markers, such as Syd-1
and Syd-2/Liprin-α, while NAB-1 binding to F-actin was also found to be
important for synapse assembly. Though at first glance rather contradictory to the
results we describe in this study, differences might result from Chia et
al.52 studying synapse assembly executed over a short time
window, when partner cells meet for the first time52. In contrast, we
used a model (Drosophila larval NMJs) where an already functional neuronal
terminal adds novel AZs1721. Despite our efforts, we were unable to
demonstrate a role of F-actin in the assembly of AZs of late larval
Drosophila NMJs. F-actin patches might be particularly important to
establish the first synaptic contacts between partner cells. Both the study by Chia
et al. and this study, however, point clearly towards important
regulatory roles of Spn family members in the presynaptic control of synapse
assembly.Further, we describe a novel interaction between the Spn-PDZ domain and the
intracellular C-term of Nrx-1 at the atomic level. Interestingly, we found that all
functions of Spn reported in this study, structural as well as functional, were
strictly dependent on the ligand-binding integrity of this PDZ domain. It is
noteworthy that the Spn-PDZ domain binds other ligands as well, for example,
Kalirin-7 and p70S6K (refs 53, 54, 55), and further
elucidation of its role as a signal ‘integrator' in synapse
plasticity should be interesting. The fact that Nrx-1 levels were increased at
Spn NMJs and, most importantly, that genetic removal of a single nrx-1
gene copy effectively suppressed the SpnAZ phenotype, indicates an
important role of the Spn/Nrx-1 interaction in this context. Affinity of Spn-PDZ for
the Nrx-1 C-term was somewhat lower than that of the Syd-1-PDZ, both in ITC and Y2H
experiments (Fig. 5c). Nonetheless, overexpression of Spn was
successful in reducing the targeting effect of Syd-1 on overexpressed
Nrx-1GFP (see above). It will be interesting to see whether this
interaction can be differentially regulated, for example, by
(de)phosphorylation.It is worth noting that apart from Syd-1 and Spn, several other proteins containing
PDZ domains, including CASK, Mint1/X11, CIPP and Syntenin133656575859, were found to bind to the Nrxs C-termini (also
see Fig. 5e,f). CASK was previously shown to interact
genetically with Nrx-1, controlling endocytic function at Drosophila
NMJs36. However, when we tested for an influence of CASK on
Nrx-1GFP motility using FRAP, genetic ablation of CASK had no
effect (Supplementary Fig. 6). Thus,
CASK function seemingly resembles neither Syd-1 nor Spn. Clearly, future work will
have to address and integrate the role of other synaptic regulators converging on
the Nrx-1 C-term. In particular, CASK (which displays a kinase function that
phosphorylates certain motifs within the Nrx-1 C-term) might alternately control
Spn- and Syd-1-dependent functions37. Presynaptic Nrx-1, through
binding to postsynaptic Nlg1 at developing Drosophila NMJ terminals, is
important for the proper assembly of new synaptic sites11131536. It is of note, however, that while mammalian Nrxs display robust synaptogenetic
activity in cellular in vitro systems, direct genetic evidence for
synaptogenetic activity of Nrxs in the mammalian CNS remained rather scarce. Triple
knockout mice lacking all α-Nrxs display no gross synaptic defects at the
ultrastructural level6061. Future analysis will have to investigate
whether differences here might be explained by specific compensation mechanisms in
mammals; for example, by β-Nrxs, or other parallel trans-synaptic
communication modules. Genuine functional deficits in neurotransmitter release were
also observed after the elimination of presynaptic Spn. Elimination of ligand
binding to the PDZ domain rendered the protein completely nonfunctional, without
affecting its synaptic targeting. Thus, the Spn functional defects are likely
to be mediated via a lack of Nrx-1 binding. Notably, ample evidence connects
Nrx-1 function with both the functional and structural maturation of
Drosophila presynaptic AZs816416263. Our work now
promotes the possibility that binding of Spn to Nrx-1 is important for establishing
correct release probability, independent of absolute AZ scaffold size (Fig. 7). It is noteworthy that Nrx-1 function was previously
shown to be important for proper Ca2+ channel function and,
as a result, properly evoked SV release60. Thus, it will be
interesting to investigate whether the specific functional contributions of Spn are
mediated via deficits in the AZ organization of voltage-gated
Ca2+ channels or Ca2+ sensors,
such as synaptotagmin646566. Taken together, we found an
unexpected function for Spn in addition of AZs at Drosophila glutamatergic
terminals, through the integration of signals from both the pre- and postsynaptic
compartment. Given that we find the Spn/Nrx-1 interaction to be conserved from
Drosophila to rodents, addressing similar roles of presynaptic Spn in
mammalian brain physiology and pathophysiology might be informative.
Methods
Genetics and molecular cloning
Fly strains were reared under standard laboratory conditions67.
Both male and female larvae were used for analysis in all experiments (except
electrophysiological recordings, see below). The structure of the
spn allele eliminating the
complete Spn locus, CG16758 (and partially deleting the CG45186 loci) was
validated by genomic PCR23. The combination of
spn
in trans with the deficiency chromosome dfBSc116 (Spn deficiency: Df)
resulted in animals deficient in the Spn locus. Lethality in Spn was
completely rescued by returning one copy of the genomic region of Spn in this
mutant background. It is of note that another mutant allele of Spn was
reported previously and was shown to be ‘semi-lethal'68; however, no functional analysis was performed in this study.
w served as a genetic background for all
experiments. Recombinations were verified using PCR or complementation analysis.
The following recombination lines were used: for
Syd-1(dsyd-1), Nrx-1
(Nrx-1) and
Nlg1(Nlg1). Flies carrying
UAS–green fluorescent protein (GFP)-tagged Nrx-1 (ref. 15), UAS–GFP or mStraw-tagged Syd-1 were
described previously13. UAS-untagged or GFP-tagged Spn were
obtained by recombining pUAST-attb-rfa and
pUAST-attb–GFP–rfa with pENTR-Spn FL, respectively. The
full-length Spn cDNA was cloned into pENTR from BDGP clone LD45234, via Spe1 and
Kpn1 restriction sites, using primers 5′- ATGGATAGCGAAAAGGTGGCCAAAC
-3′ and 5′- CTTCTTTTTGGCCGCCTTCTTCTC -3′.A rabbit polyclonal anibody was raised against a 6 × His-tagged fusion
protein of Spn N-term region (Fig. 1a, green bar). The
corresponding expression construct was cloned after PCR with 5′-
CACCAGCGTTCTCATCCAGTC -3′ and 5′- TTACACAATGTCCACGGCTTCA
-3′ primers, and TOPO cloned into pENTR D-TOPO.The point-mutated PDZ domain of Spn cDNA (PDZ*Spn cDNA)
was constructed by circular PCR using primers: 5′-
GTGGAATTGATGGCGGGTCCTGAGGGTGCGGGTCTCAGTATAATTG -3′ and 5′-
CAATTATACTGAGACCCGCACC CTCAGGACCCGCCATCAA TTCCAC -3′.
Clonings for crystal trials, ITC and GST pull-down assays
The constructs comprising the PDZ domains of dmSpn (residue
1,258–1,347), dmSyd-1 (residue 155–242) and
rnSpn (residue 493–583) were amplified by PCR and cloned into
the pET-MBP vector using NcoI and SalI restriction sites with primers:
dmSpn_fwd: 5′- TATACCATGGCGCATGTCTTCCCCGTGG -3′,
dmSpn_rev: 5′- TATA CCATGGTGGCCGCTTCGG -3′,
dmSyd-1_fwd:5′- TATACCATGGCGCAGGCGGTCGATGC -3′,
dmSyd-1_rev:5′- TATACCATGGCGCACACGGTTCAACTTGTCG
-3′, rnSpn_fwd: 5-′ TATACCATGGAGCTGTTTCCTGTGGAG
-3′ and rnSpn_rev: 5′- ATATGTCGACCTACTCCCGGCCAATCATG
-3′.The resulting constructs contained an N-terminal His6-MBP-tag followed by a
tobacco etch virus cleavage site and the respective PDZ domain. The constructs
comprising the last 10 C-terminal amino acids of dmNrx-1 (residue
1,831–1,840) and rnNrx-1 (residue 1,498–1,507) were
amplified by PCR and cloned into the pGEX-6-P1 vector by a SLIC reaction using
overlapping primers: dmNrx-1ct_fwd: 5′- GACTCCAAGGACGTCAAGGAGTGGTATG
TGTAACTGACGATCTGCCTCG -3′, dmNrx-1 ct_rev: 5′-
TTACACATACCACTCCTTGACGTC CTTGG AGTC GTCACGATGCGGCC -3′,
rNrx-ct_fwd: 5′- AAGAAGAACAAAGACAAAGAGTATTACGTCTAGCTG
ACGATCTGCCTCG -3′, rNrx-1ct_rev: 5′-
CTAGACGTAATACTCTTTGTCTTTGTTCTTCTTGTCAC GA TGCGGCC-3′.The resulting constructs comprised an N-terminal GST-tag followed by a
PreScission cleavage site and the respective 10 C-terminal amino acids of Nrx-1.
Detailed version of methods for Protein expression and purification, ITC assays
and crystallization are presented in Supplementary Methods.
Generation of Spn genomic constructs
Pac (Spn1) was created from P[acman] BAC clone
CH321-01N11 (genomic region 2499270 to 2581398; CHORI-321 library of the BACPAC
Resource Centre), which was subjected to transgenesis using the Phi31 system
(P[acman] strain 24872, M[vas-int.Dm]ZH-2A,
PBac[y[+]-attP- 3B]VK00037).
Similarly, Pac(Spn2) was obtained by injecting the
P[acman] BAC clone CH321-67O06 (genomic region 2469714 to
2556468). Pac(Spn*) corresponds to P[acman] BAC clone
CH321-67O06, but lacks the whole Spn open reading frame, and was cloned
according to the Counter Selection BAC Modification kit obtained from Gene
Bridges GmbH. rpsL-neomycin (neo) template DNA was used to generate selectable
cassettes. Primers contained a 50-bp homology region and a sequence for
amplification of the rpsL-neo counter selection cassette. Selectable cassettes
were generated by PCR using Vent Polymerase (New England Biolabs, Inc.) and the
following primer pairs. Spn-rpsL-fwd:5′-
GGCCCGAAATTCAAGCTAAACGGACGCGTTTTCGTCGCGAGTTTAACC GCGGCCTGGTGATGATGGCGGGATCG
-3′, Spn-rpsL-rev: 5′-
ATTTCAGAGTATATTTATTAGCACTGATTTTGAGATTTATT ATTTTCCATTCAGAAGAACTCGTCAAGAAGGCG
-3′.
Yeast-2-hybrid clones
Yeast-2-hybrid analysis was carried out using the LexA system (pB27 bait vector;
pP6 bait vector). The cytoplasmic C terminus of Nrx-1 was cloned into pB27 using
primers: 5′- GATGGAATTC-AATGGCGATCGTGGCT -3′ and
5′- GTCTATACTAGT-TTACACATACCACTCCTTGACGTCCT -3′.The Spn and Syd-1 fragments depicted in Fig. 6 were cloned
into pP6 using: F1-fwd: 5′- CAATTCCATGGC-CATGGAGAAACCGATGCATCAT
-3′, F1-rev: 5′- CAACCTCGAGTTA-ATA GC CGACGTCCACGTA
-3′, F2-fwd: 5′- CAAACCATGGCC-GGTCGCAAATCTGTGGACG
-3′, F2-rev: 5′- CTTGGATCCTT-ACTCGTGCAGTGATTCCCC
-3′, F3-fwd: 5′- GATCCATGGCC-CGTGAAGAGCTGGAAAAC
-3′, F3-rev: 5′- GTTGGATCCTTA-CGTCTTACGCATCATCTG
-3′, F4-fwd: 5′- GATCccatggccGAGGAGCGCTTGAAGCGCCAA
-3′, F4-rev: 5′- CTGGGATCCTTGTGCACCTGGGCATA -3′,
F5-fwd: 5′- GATC CCATGGCCAACTCGCATCTGCTGGCCAACGTG -3′,
F5-rev: 5′- GGAATCCTCGAG-CTTCTTTTTGGCCGCCTTCTTCT -3′, Syd-1
F1-fwd: 5′- GTCTATGAATTC ATGACG GTGC AACC GGCTGAA -3′, Syd-1
F1-rev: 5′- GTCTATACT-AGTT CCCGTT GACATTC TTCTCG -3′.
Immunostaining and imaging
Larval filets were dissected and stained as described previously1321. Primary antibodies used were: rabbit (Rb)
SPNN2.2 (1:3,000), RbGluRIID (1:500), RbDSyd-1 (1:500),
RbNlg1 (1:500), RbDRBP (1:500) and guinea pigNrx-1 (1:500) (generously provided
by M. Bhat). We used MNc82 (1:100) and MCSP (1:500) (Developmental Studies
Hybridoma Bank (DSHB), the University of Iowa, Iowa City, IA), MFasII (1D4;
DSHB), mouse monoclonal antibody 3E6 (to stain GFP) (1:500) (Invitrogen) and
rabbit anti-dsRed (1:500) (Clontech). Secondary antibodies were generally
diluted 1:500. Secondary antibodies for STED were used in the following
concentrations: goat anti-mouse Atto590 1:100 and goat anti-rabbit star635
1:100. The dyes Atto590 (ATTO-TEC) and Star635 (Abberior) were coupled to the
stated IgGs (Dianova). Imaging larvae were mounted in Mowiol (Sigma-Aldrich) for
STED.The sizes and surface densities of AZ cluster (visualized using
BRPnc82, RimBP and CacGFP) were quantified
from maximal projections of confocal NMJ stacks. A Cy5-HRP antibody (23-175-021,
Jackson ImmunoResearch, 1:250) was used to outline the shape of the NMJ. Control
and mutant larvae were stained in the same vial. All images for synapse
quantification from fixed samples were acquired using the same microscope
settings (with × 63 magnification and numerical aperture 1.4 oil
objective, Leica). AZ cluster analysis was done as described previously69; AZ densities were obtained by normalizing the total number of
particles analysed to the total synaptic area (pixel units) measured via HRP.
Similarly, the absolute intensities of synaptic proteins per NMJ were normalized
to the absolute intensity of synaptic HRP of the corresponding NMJ.
In vivo imaging and FRAP analysis
All UAS constructs were driven in motoneurons using OK6-Gal475.
Intravital live imaging was performed as described previously1321.
STED and EM
STED microscopy was performed as described previously30. BRP ring
diameter measurements were performed on deconvolved images. Line profiles were
placed across the middle of planer-oriented BRP rings and the longest
peak-to-peak distance measured. Five to seven images obtained from four to five
third instar larvae per genotype were processed and analysed.
Head fractionation, co-immunoprecipitation and Y2H assay
We followed a new protocol using Drosophila head fractionation, to obtain
protein extracts used in co-immunoprecipitation experiments. Extracts were run
on 6% Tris_HCl gels. Proteins were then transferred onto a
nitrocellulose membrane and blocked with 5% milk in 1 × PBS
supplemented with 0.1% Tween-20 (PBS-T). Membranes were probed with
guinea pig anti-Nrx-1 (1:5,000; a custom polyclonal directed against the last
100 amino acids of Nrx-1) and rabbit anti-SpnN2.2 (1:10,000)
diluted in PBS-T. After washing, secondary anti-guinea pig or anti-rabbit
HRP-conjugated antibodies were used for detection (Dianova) in conjunction with
an enhanced chemoluminescence (GE Healthcare ECL Prime; product number RPN 2232)
detection system with Hyperfilm ECL (GE Healthcare). Films were scanned in
transmission mode (Epson V770). Images were imported to Photoshop (Adobe), and
brightness and contrast were adjusted. The liquid Y2H
β-galactosidase assay was performed as reported previously70.
Co-immunoprecipitation from mouse brain
Brains were homogenized in 25 ml per g tissue in homogenization buffer
(50 mM Tris-HCL, pH7.4, 150 mM NaCl, 10%
glycerol, 2 mM caCl2+EDTA free protease and phosphatase
inhibitor mixes) using glass homogenizer. After homogenization samples were
sonicated with 3 × 10 pulses, Triton-X100 was added to the final
concentration of 1% and homogenate was incubated for
10 min at 4 °C with rotation. Sample was sonicated
again with 10 pulses. Samples were spun down at 20,000 × g for
30 min. About 10 μl per ml homogenate of
protein A/G magnetic beads were added following 30 min incubation and
separation of magnetic beads from the homogenate. Homogenate was aliquoted in
2 ml tubes (1.6 ml per tube) and
0.8 μg affinity-purified anti-pan-NRX or rabbit IgG was
added to each aliquot. Samples were incubated overnight with rotation at
4 °C. About 8 μl protein-A magnetic
beads (Dynabeads) were added and samples were incubated for additional
2 h. Samples were washed 3 × with homogenization
buffer+0.1% Triton-X100 and once with homogenization buffer
without detergent. Bound proteins were eluted with 30 μl
2% sodium deoxycholate. Eluted proteins were separated on
8% PAA gel and probed with anti-spinophilin (1:1,000, Cell Signaling,
E1E7R) and anti-pan-Nrx
(40 μg ml−1,
homemade, affinity purified).
Two-electrode voltage clamp recordings
TEVC recordings were performed on larval NMJs of third instar males (muscle 6 and
segments A2 and A3), essentially as described6. The composition
of the extracellular hemolymph-like saline (HL-3) was (in mM) NaCl 70, KCl 5,
MgCl2 20, NaHCO3 10, trehalose 5, sucrose 115, HEPES 5 and CaCl2 1.5,
pH adjusted to 7.2. Recordings were made from cells with an initial membrane
potential (Vm) between −50 and −70 mV and
input resistances of ⩾4 MΩ, using intracellular
electrodes with resistances of 8–20 MΩ and filled
with 3 M KCl. eEJCs, which reflect the compound excitatory junctional
current of both the motoneurons innervating muscle 6 (voltage clamp at
−60 mV) and mEJCs (voltage clamp at
−80 mV) were low pass filtered at 1 kHz. The
0.2-Hz stimulation protocols included 20 traces per cell. Paired-pulse
recordings consisted of 10 traces per interval per cell in which a 4-s rest was
left between paired pulses. For determination of the base line of the second
pulse at the 10-ms interpulse interval, the decay of the first pulse was
extrapolated. Recordings were analysed with pClamp 10 (Molecular Devices).
Stimulation artifacts in eEJC recordings were removed for clarity.
GCaMP5 imaging; assaying spontaneous and evoked release by
Ca2+ imaging
Optical analysis of spontaneous and evoked transmitter release was performed
similarly as described3 by imaging postsynaptic GCaMP5
fluorescence signals in flies expressing UAS-myrGCaMP5. Local activity patterns
were aligned to confocal images of a post-fixed staining against GFP and BRP to
identify single AZs. See Supplementary
Methods for full details of Ca2+ imaging,
image alignment and signal processing.
Statistics
Data were analysed using Prism (GraphPad Software). Nonparametric
Mann–Whitney U-tests were used to compare two groups for all
data sets. Nonparametric Kruskal–Wallis tests were used for comparison
of more than two groups, followed by a Dunn's multiple comparison
test. P values, n values and U or K statistics are
given in the figure legends or main text. Similarly, the electrophysiological
data are reported as mean±s.e.m. and P value denotes the
significance according to one-way analysis of variance with Tukey's
multiple comparison post-test.
Additional information
Author Information. The structure factors and atomic coordinates of the
Spn-PDZ domain are deposited in the Protein Data Bank with accession number
4XHV.How to cite this article: Muhammad, K. G. H. et al. Presynaptic
spinophilin tunes neurexin signalling to control active zone architecture and
function. Nat. Commun. 6:8362 doi: 10.1038/ncomms9362 (2015).
Authors: Markus Missler; Weiqi Zhang; Astrid Rohlmann; Gunnar Kattenstroth; Robert E Hammer; Kurt Gottmann; Thomas C Südhof Journal: Nature Date: 2003-06-26 Impact factor: 49.962
Authors: Stephan J Sigrist; Dierk F Reiff; Philippe R Thiel; Joern R Steinert; Christoph M Schuster Journal: J Neurosci Date: 2003-07-23 Impact factor: 6.167
Authors: Weiqi Zhang; Astrid Rohlmann; Vardanush Sargsyan; Gayane Aramuni; Robert E Hammer; Thomas C Südhof; Markus Missler Journal: J Neurosci Date: 2005-04-27 Impact factor: 6.167
Authors: Fabian Göttfert; Christian A Wurm; Veronika Mueller; Sebastian Berning; Volker C Cordes; Alf Honigmann; Stefan W Hell Journal: Biophys J Date: 2013-07-02 Impact factor: 4.033
Authors: Bulent Ataman; James Ashley; David Gorczyca; Michael Gorczyca; Dennis Mathew; Carolin Wichmann; Stephan J Sigrist; Vivian Budnik Journal: Proc Natl Acad Sci U S A Date: 2006-05-08 Impact factor: 11.205
Authors: Annette L Parks; Kevin R Cook; Marcia Belvin; Nicholas A Dompe; Robert Fawcett; Kari Huppert; Lory R Tan; Christopher G Winter; Kevin P Bogart; Jennifer E Deal; Megan E Deal-Herr; Deanna Grant; Marie Marcinko; Wesley Y Miyazaki; Stephanie Robertson; Kenneth J Shaw; Mariano Tabios; Valentina Vysotskaia; Lora Zhao; Rachel S Andrade; Kyle A Edgar; Elizabeth Howie; Keith Killpack; Brett Milash; Amanda Norton; Doua Thao; Kellie Whittaker; Millicent A Winner; Lori Friedman; Jonathan Margolis; Matthew A Singer; Casey Kopczynski; Daniel Curtis; Thomas C Kaufman; Gregory D Plowman; Geoffrey Duyk; Helen L Francis-Lang Journal: Nat Genet Date: 2004-02-22 Impact factor: 38.330
Authors: Janus Rl Kobbersmed; Andreas T Grasskamp; Meida Jusyte; Mathias A Böhme; Susanne Ditlevsen; Jakob Balslev Sørensen; Alexander M Walter Journal: Elife Date: 2020-02-20 Impact factor: 8.140
Authors: Peri T Kurshan; Sean A Merrill; Yongming Dong; Chen Ding; Marc Hammarlund; Jihong Bai; Erik M Jorgensen; Kang Shen Journal: Neuron Date: 2018-09-27 Impact factor: 17.173
Authors: Santiago Balseiro-Gómez; Junhyun Park; Yang Yue; Chen Ding; Lin Shao; Selim Ҫetinkaya; Caroline Kuzoian; Marc Hammarlund; Kristen J Verhey; Shaul Yogev Journal: Dev Cell Date: 2022-07-08 Impact factor: 13.417
Authors: Zachary L Newman; Adam Hoagland; Krishan Aghi; Kurtresha Worden; Sabrina L Levy; Jun Ho Son; Luke P Lee; Ehud Y Isacoff Journal: Neuron Date: 2017-03-09 Impact factor: 17.173
Authors: Niraja Ramesh; Marc J F Escher; Malou M Mampell; Mathias A Böhme; Torsten W B Götz; Pragya Goel; Tanja Matkovic; Astrid G Petzoldt; Dion Dickman; Stephan J Sigrist Journal: Curr Biol Date: 2021-03-01 Impact factor: 10.834